4//SEC Filing
Martin Tami Tillotson 4
Accession 0001104659-23-025370
CIK 0001356576other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:02 PM ET
Size
7.3 KB
Accession
0001104659-23-025370
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Common Stock
2023-02-22+750→ 90,323 total - Disposition to Issuer
Restricted Stock Units
2023-02-22−750→ 2,250 total→ Common Stock (750 underlying)
Footnotes (3)
- [F1]Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:02 PM ET
- Size
- 7.3 KB